Marker | Negative | Low | Intermediate | High |
---|---|---|---|---|
EGFR (n = 101) | 41 (40.6%) | 22 (21.8%) | 26 (25.7%) | 12 (11.9%) |
PIK3CA (n = 101) | 1 (1.0%) | 0 (0%) | 13 (12.9%) | 87 (86.1%) |
PTEN (n = 100) | 69 (69.0%) | 5 (5.0%) | 26 (26.0%) | 0 (0%) |
p-mTOR (n = 101) | 37 (36.6%) | 22 (21.8%) | 41 (40.6%) | 1 (1.0%) |
p-AKT cytoplasmic (n = 101) | 11 (10.9%) | 5 (5.0%) | 47 (46.5%) | 38 (37.6%) |
p-AKT nuclear (n = 101) | 45 (44.6%) | 4 (4.0) | 31 (30.7%) | 21 (20.8%) |
p-MAPK/Erk1/2 cytoplasmic (n = 102) | 31 (30.4%) | 14 (13.7%) | 57 (55.9%) | 0 (0%) |
p-MAPK/Erk1/2 nuclear (n = 102) | 27 (26.5%) | 11 (10.8%) | 64 (62.7%) | 0 (0%) |